| 名称 持有数量(万股) | | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 宁波大牧投资有限公司 | 4709.26 | 50.44 | 不变 | | 浙江嘉拓投资管理有限公司 | 933.67 | 10.00 | 不变 | | 凯恩(苏州)私募基金管理有限公司-凯恩军舰鸟1号私募 证券投资基金 | 89.89 | 0.96 | -39.51 | | 陈远山 | 88.77 | 0.95 | 新进 | | 凯恩(苏州)私募基金管理有限公司-凯恩军舰鸟19号私募 证券投资基金 | 84.51 | 0.91 | -37.88 | | 黄敏勇 | 70.91 | 0.76 | 11.97 | | 图灵私募基金管理(海南)有限公司-图灵璟龙一号私募证 券投资基金 | 54.95 | 0.59 | 不变 | | 张晓沛 | 49.19 | 0.53 | 新进 | | 凯恩(苏州)私募基金管理有限公司-凯恩新经济1号私募 证券投资基金 | 31.25 | 0.33 | -6.55 | | 徐云霞 | 30.31 | 0.32 | 新进 ...

| 名称 持有数量(万股) | | 占总股本比例 | 增减情况(万 | | --- | --- | --- | --- | | | | (%) | 股) | | 浙江平处贸易有限公司 | 21150.17 | 6.68 | -989.12 | | 王健 | 16063.29 | 5.07 | -1679.33 | | 朱志刚 | 7831.31 | 2.47 | 不变 | | 香港中央结算有限公司 | 6489.20 | 2.05 | 2790.01 | | 南方中证1000ETF | 2325.56 | 0.73 | -957.81 | | 华夏中证1000ETF | 1245.73 | 0.39 | -545.41 | | 广发中证1000ETF | 965.50 | 0.30 | -207.52 | | MORGAN STANLEY & CO. INTERNATIONAL PLC. | 619.66 | 0.20 | 新进 | | 陈振宇 | 529.88 | 0.17 | 新进 | | 陈家琼 | 504.82 | 0.16 | 新进 | | 较上个报告期退出前十大股东有 | | | | | 中国人寿 ...

Financial Performance - The company reported a basic earnings per share of 1.29 yuan for 2024, an increase of 7.5% compared to 1.20 yuan in 2023 [1] - The net profit for 2024 was 1.3 billion yuan, reflecting a 6.56% increase from 1.22 billion yuan in 2023 [1] - Operating revenue reached 7.02 billion yuan, up 19.39% from 5.88 billion yuan in the previous year [1] - The return on equity (ROE) improved to 9.45% in 2024 from 9.21% in 2023 [1] - The net asset per share increased to 14 yuan, a 6.46% rise from 13.15 yuan in 2023 [1] - The undistributed profits per share saw a significant increase of 35.51%, reaching 3.74 yuan compared to 2.76 yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 589.46 million shares, accounting for 20.1% of the circulating shares, which is a decrease of 550,000 shares from the previous period [1] - Notable changes among the top shareholders include a decrease in holdings for several individuals, such as Xie Jianyong, who reduced his stake by 4.6% to 187.04 million shares [2] - Morgan Stanley & Co. International PLC entered the top ten shareholders with a new holding of 17.55 million shares [2] Dividend Distribution - The company announced a dividend distribution plan of 3 yuan per share (including tax) [2]

| 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | 许世俊 | 1735.00 | 14.24 | 新进 | | 许成辰 | 785.34 | 6.45 | 新进 | | 南通海力股权投资中心(有限合伙) | 586.04 | 4.81 | 新进 | | 沙德权 | 543.03 | 4.46 | 不变 | | 如东县新天和资产管理有限公司 | 316.58 | 2.60 | -37.93 | | 赵小兵 | 254.48 | 2.09 | 不变 | | 香港中央结算有限公司 | 193.63 | 1.59 | 40.24 | | 沈飞 | 190.61 | 1.56 | -21.60 | | 贝莱德中国新视野混合A | 168.00 | 1.38 | 新进 | | 南通润熙股权投资中心(有限合伙) | 166.99 | 1.37 | -4.21 | | 较上个报告期退出前十大股东有 | | | | | 钟格 | 815.56 | 8.95 | 退出 | | 常州泰珅私募投资基金有限公司-如东鑫濠产业 ...

前十大流通股东累计持有： 1423.79万股，累计占流通股比： 22.67%，较上期变化： -763.40万股。 | 名称 | 持有数量(万股) | 占总股本比 | 增减情况 | | --- | --- | --- | --- | | | | 例(%) | (万股) | | 开源证券股份有限公司 | 301.93 | 4.81 | -9.00 | | 溪牛投资管理(北京)有限公司-溪牛长期回报私募证券投资基 | | | | | 金 | 282.26 | 4.50 | -44.43 | | 张建波 | 175.39 | 2.79 | 7.50 | | 海能未来技术集团股份有限公司回购专用证券账户 | 160.00 | 2.55 | 新进 | | 许鸣 | 153.90 | 2.45 | 不变 | | 胡玉兰 | 146.45 | 2.33 | 不变 | | 穆俊林 | 109.26 | 1.74 | -22.13 | | 张振方 | 64.86 | 1.03 | 8.25 | | 刘文玉 | 29.74 | 0.47 | 新进 | | 较上个报告期退出前十大股东有 | | | | | 王志刚 | 398.00 ...

二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 133957.61万股，累计占流通股比： 56.38%，较上期变 化： -1221.04万股。 一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 1.6000 | 1.7800 | -10.11 | 1.6400 | | 每股净资产（元） | 10.4 | 9.15 | 13.66 | 7.45 | | 每股公积金(元) | 2.28 | 2.12 | 7.55 | 1.8 | | 每股未分配利润(元) | 6.72 | 5.65 | 18.94 | 4.33 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 370.41 | 304.2 | 21.77 | 230.08 | | 净利润(亿元) | 42.85 | 47.42 | -9.64 | 43.2 | | 净资产收益率(%) | 16.52 | 21.66 | -23.73 ...

Financial Performance - The company's basic earnings per share decreased to 0.1500 yuan in 2024 from 0.2100 yuan in 2023, representing a decline of 28.57% [1] - The net profit for 2024 was 0.4 billion yuan, down 31.03% from 0.58 billion yuan in 2023 [1] - Operating revenue fell to 2.69 billion yuan in 2024, a decrease of 14.33% compared to 3.14 billion yuan in 2023 [1] - The return on equity (ROE) dropped to 6.08% in 2024 from 8.61% in 2023, marking a decline of 29.38% [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 14.1447 million shares, accounting for 17.6% of the circulating shares, which is a decrease of 1.1042 million shares from the previous period [1] - Guangdong Yongshun Biopharmaceutical Co., Ltd. remains unchanged with 360.00 million shares, representing 4.48% of total share capital [2] - Cai Jianping's holdings decreased by 22.00 million shares, now totaling 319.97 million shares, or 3.98% of total share capital [2] Dividend Distribution - The company announced a dividend distribution plan of 1.3 yuan per share (including tax) [2]

Financial Performance - The company reported a basic earnings per share of -0.3000 yuan for 2024, a decrease of 172.73% compared to -0.1100 yuan in 2023 [1] - The net profit for 2024 was -1.1 billion yuan, which is a 175% increase in losses from -0.4 billion yuan in 2023 [1] - Operating revenue increased significantly to 5.01 billion yuan in 2024, up 121.68% from 2.26 billion yuan in 2023 [1] - The return on equity for 2024 was -40.71%, a decline of 159.46% from -15.69% in 2023 [1] Shareholder Information - The top ten unrestricted shareholders collectively hold 15,354.33 million shares, accounting for 41.98% of the circulating shares, with an increase of 479.58 million shares compared to the previous period [2] - Hainan Liansheng Technology Co., Ltd. remains the largest shareholder with 5,160.16 million shares, representing 14.11% of the total share capital [3] - New entrants among the top shareholders include Huaxia Industry Prosperity Mixed Fund and Huaxia Vision Growth One-Year Holding Mixed A, while Su Jianguo and Sichuan Haizi Investment Management Co., Ltd. have exited the top ten shareholders [3] Dividend Distribution - The company has announced no dividend distribution or capital increase for the current period [2]

一、主要会计数据和财务指标 | 报告期指标 | 2024年年报 | 2023年年报 | 本年比上年增减(%) | 2022年年报 | | --- | --- | --- | --- | --- | | 基本每股收益（元） | 0.5400 | 0.1200 | 350 | 0.3000 | | 每股净资产（元） | 8.75 | 8.55 | 2.34 | 8.63 | | 每股公积金(元) | 5.47 | 5.5 | -0.55 | 5.46 | | 每股未分配利润(元) | 2.00 | 1.97 | 1.52 | 1.92 | | 每股经营现金流(元) | - | - | - | - | | 营业收入(亿元) | 6.31 | 5.33 | 18.39 | 6.13 | | 净利润(亿元) | 0.66 | 0.15 | 340 | 0.37 | | 净资产收益率(%) | 6.14 | 1.38 | 344.93 | 3.46 | 三、分红送配方案情况 10派4.5元(含税) 二、前10名无限售条件股东持股情况 前十大流通股东累计持有： 9146.06万股，累计占流通股比： 73.79%，较上期变化 ...

Financial Performance - The basic earnings per share for 2024 is 0.5900 yuan, an increase of 37.21% compared to 0.4300 yuan in 2023 [1] - The net profit for 2024 is 2.55 billion yuan, reflecting a growth of 36.36% from 1.87 billion yuan in 2023 [1] - The return on equity for 2024 stands at 16.60%, up 31.96% from 12.58% in 2023 [1] - The total revenue for 2024 is 17.77 billion yuan, a 9.09% increase from 16.29 billion yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 21,148.53 million shares, accounting for 48.2% of the circulating shares, which is a decrease of 763.34 million shares from the previous period [1] - Zhang Qinghua remains the largest shareholder with 15,601.95 million shares, representing 35.56% of the total share capital, unchanged from the previous report [2] - The E Fund Healthcare Industry Mixed A fund has decreased its holdings by 588.07 million shares [2] Dividend Distribution - No specific details on the dividend distribution plan are provided in the documents [1][2]